As researchers pioneer the testing of a new vaccine that could protect against malaria, health workers and development practitioners working in Africa are optimistic that the illness will soon meet the same demise as polio. The vaccine, a project twenty years in the making, has been developed by British pharmaceutical corporations GlaxoSmithKline. It is called Mosquitrix, and if tests are successful, it could become available in only two short years.
Malaria kills one child every thirty seconds, making it one of the world’s most dangerous child killers. The majority of all cases occur in Africa and most of the children infected are under five years old. While both treatment and prevention are possible, too many people do not have the resources—both financial and medical—to access either.
http://www.soschildrensvillages.ca/News/News/child-charity-news/Pages/Child-Malaria-Vaccine-162.aspx
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment